Journal of Cardiac Failure
Volume 16, Issue 1 , Pages 2-8, January 2010

Highlights of the 2009 Scientific Sessions of the Heart Failure Society of America, Boston, MA, September 13-16, 2009

  • Christopher M. O'Connor, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • Corresponding Author InformationReprint requests: Christopher M. O'Connor, MD, Duke University Medical Center, 2301 Erwin Road, Box 3356, Durham, NC 27710. Tel: 919-681-6195.
  • ,
  • Walter J. Koch, PhD

      Affiliations

    • Thomas Jefferson University, Jefferson Medical College, Philadelphia, PA
  • ,
  • Douglas L. Mann, MD

      Affiliations

    • Washington University School of Medicine, St. Louis, MO

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. O'Connor has received research funding from NHLBI, Merck, Medtronic, Johnson and Johnson and Bioheart. Dr. Mann has received research funding from the NIH and serves as a consultant for Acorn Cardiovascular, ARMGO Pharma, Cardiokine, Circulate, Medtronic, Miragen, Mile Pharmaceuticals and Novartis.

PII: S1071-9164(09)01174-9

doi:10.1016/j.cardfail.2009.11.001

Journal of Cardiac Failure
Volume 16, Issue 1 , Pages 2-8, January 2010